Molecular therapies for cancer are revolutionizing the landscape of cancer treatment innovation, offering promising avenues for targeted cancer therapies that can hone in on the specific genetic mutations driving tumor growth.Recent studies by researchers at Harvard highlight the power of molecular glues—small compounds that can manipulate protein interactions, thereby disrupting the pathways that cancers rely on for survival.